Expansion of immunostimulatory dendritic cells from peripheral blood of patients with cancer

Oncologist

Volumn 2, Issue 1, 1997, Pages 65-69

  Siena, Salvatore ^a   Di Nicola, Massimo ^a   Mortarini, Roberta ^a   Anichini, Andrea ^a   Bregni, Marco ^a   Parmiani, Giorgio ^a   Gianni, Alessandro M ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR VACCINE;

ANTIGEN PRESENTING CELL; CANCER IMMUNOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; IMMUNOSTIMULATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW;

EID: 0030974890     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-1-65     Document Type: Review

References (8)

1. Steinman RM. Dendritic cells and immune-based therapies. Exp Hematol 1996;24:859-862.
2. Lanzavecchia A. Identifying strategies for immune intervention. Science 1993;260:937-944.
3. Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995;16:2-4.
4. Mackensen A, Herbst B, Kohler G et al. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 1995;86:2699-2707.
5. + blood progenitors for anticancer therapy. Exp Hematol 1995;23:1463-1471.
6. + cell-derived versus monocyte-derived autologous dendritic cells. Haematologica 1996;81:83.
7. Young JW, Inaba K. Dendritic cells as adjuvants for class 1 major histocompatibility complex-restricted antitumor immunity. J Exp Med 1996;183:7-11.
8. Grabbe S, Brivers S, Gallo RL. Tumor antigen presentation by murine epidermal cells. J Immunol 1991;146:3656-3661.